Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model

DMM Disease Models and Mechanisms

Volumn 9, Issue 5, 2016, Pages 513-527

  Parkinson, William M ^a   Dookwah, Michelle ^b   Dear, Mary Lynn ^a   Gatto, Cheryl L ^a,c   Aoki, Kazuhiro ^d   Tiemeyer, Michael ^b,d   Broadie, Kendal ^a,c,e  

^a VANDERBILT UNIVERSITY   (United States)

^b University of Georgia ^*  (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Matrix metalloproteinase; Neuromuscular junction; Neurotransmission; Synapse; Synaptomatrix; Trans synaptic signaling; Wnt

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; PHOSPHOMANNOMUTASE; PHOSPHOMANNOMUTASE TYPE 2; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; WNT PROTEIN; DROSOPHILA PROTEIN; GLYCOPROTEIN; MUTASE; OLIGOSACCHARIDE; PMM2 PROTEIN, DROSOPHILA; POLYSACCHARIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1A; CONTROLLED STUDY; DROSOPHILA; FEMALE; GENE FUNCTION; LETHALITY; LIFESPAN; MALE; NEUROMUSCULAR JUNCTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PSYCHOMOTOR RETARDATION; RNA INTERFERENCE; SYNAPSE; SYNAPTOGENESIS; ANIMAL; BODY POSITION; CONGENITAL DISORDER OF GLYCOSYLATION; DEFICIENCY; DISEASE MODEL; DOWN REGULATION; ENZYMOLOGY; EXTRACELLULAR MATRIX; GLYCOSYLATION; LONGEVITY; METABOLISM; MOVEMENT (PHYSIOLOGY); NERVE ENDING; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; CONGENITAL DISORDERS OF GLYCOSYLATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DROSOPHILA; DROSOPHILA PROTEINS; EXTRACELLULAR MATRIX; GLYCOPROTEINS; GLYCOSYLATION; LONGEVITY; MOVEMENT; NEUROMUSCULAR JUNCTION; OLIGOSACCHARIDES; PHOSPHOTRANSFERASES (PHOSPHOMUTASES); POLYSACCHARIDES; POSTURE; PRESYNAPTIC TERMINALS; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84966460670     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.022939     Document Type: Article

References (88)

1. Abramoff, M. D., Magalhaes, P. J. and Ram, S. J. (2001). Image processing with Image J. Biophotonics Int. 11, 36-42.
2. Altmann, F., Fabini, G., Ahorn, H. and Wilson, I. B. H. (2001). Genetic model organisms in the study of N-glycans. Biochimie 83, 703-712.
3. Andreotti, G., Cabeza de Vaca, I., Poziello, A., Monti, M. C., Guallar, V. and Cubellis, M. V. (2014). Conformational response to ligand binding in phosphomannomutase2: insights into inborn glycosylation disorder. J. Biol. Chem. 289, 34900-34910.
4. Aoki, K., Perlman, M., Lim, J.-M., Cantu, R., Wells, L. and Tiemeyer, M. (2007). Dynamic developmental elaboration of N-linked glycan complexity in the Drosophila melanogaster embryo. J. Biol. Chem. 282, 9127-9142.
5. Ataman, B., Ashley, J., Gorczyca, D., Gorczyca, M., Mathew, D., Wichmann, C., Sigrist, S. J. and Budnik, V. (2006). Nuclear trafficking of Drosophila Frizzled-2 during synapse development requires the PDZ protein dGRIP. Proc. Natl. Acad. Sci. USA 103, 7841-7846.
6. Ataman, B., Ashley, J., Gorczyca, M., Ramachandran, P., Fouquet, W., Sigrist, S. J. and Budnik, V. (2008). Rapid activity-dependent modifications in synaptic structure and function require bidirectional Wnt signaling. Neuron 57, 705-718.
7. Barone, R., Fiumara, A. and Jaeken, J. (2014). Congenital disorders of glycosylation with emphasis on cerebellar involvement. Semin. Neurol. 34, 357-366.
8. Barone, R., Carrozzi, M., Parini, R., Battini, R., Martinelli, D., Elia, M., Spada, M., Lilliu, F., Ciana, G., Burlina, A. et al. (2015). A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation. J. Neurol. 262, 154-164.
9. Brand, A. H. and Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415.
10. Cline, A., Gao, N., Flanagan-Steet, H., Sharma, V., Rosa, S., Sonon, R., Azadi, P., Sadler, K. C., Freeze, H. H., Lehrman, M. A. et al. (2012). A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency. Mol. Biol. Cell. 23, 4175-4187.
11. Cylwik, B., Naklicki, M., Chrostek, L. and Gruszewska, E. (2013). Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation. Acta Biochim. Pol. 60, 151-161.
12. Dani, N. and Broadie, K. (2012). Glycosylated synaptomatrix regulation of transsynaptic signaling. Dev. Neurobiol. 72, 2-21.
13. Dani, N., Nahm, M., Lee, S. and Broadie, K. (2012). A targeted glycan-related gene screen reveals heparan sulfate proteoglycan sulfation regulates WNT and BMP trans-synaptic signaling. PLoS Genet. 8, e1003031.
14. Dani, N., Zhu, H. and Broadie, K. (2014). Two protein N-acetylgalactosaminyl transferases regulate synaptic plasticity by activity-dependent regulation of integrin signaling. J. Neurosci. 34, 13047-13065.
15. de la Morena-Barrio, M. E., Hernández-Caselles, T., Corral, J., García-López, R., Martínez-Martínez, I., Pérez-Duenas, B., Altisent, C., Sevivas, T., Kristensen, S. R., Guillén-Navarro, E. et al. (2013). GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients. Orphanet. J. Rare Dis. 8, 170.
16. de Lonlay, P., Seta, N., Barrot, S., Chabrol, B., Drouin, V., Gabriel, B. M., Journel, H., Kretz, M., Laurent, J., Le Merrer, M. et al. (2001). A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J. Med. Genet. 38, 14-19.
17. Dear, M. L., Dani, N., Parkinson, W., Zhou, S. and Broadie, K. (2016). Two classes of matrix metalloproteinases reciprocally regulate synaptogenesis. Development 143, 75-87.
18. Freeze, H. H., Chong, J. X., Bamshad, M. J. and Ng, B. G. (2014). Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am. J. Hum. Genet. 94, 161-175.
19. Freeze, H. H., Eklund, E. A., Ng, B. G. and Patterson, M. C. (2015). Neurological aspects of human glycosylation disorders. Annu. Rev. Neurosci. 38, 105-125.
20. Friedman, S. H., Dani, N., Rushton, E. and Broadie, K. (2013). Fragile X mental retardation protein regulates trans-synaptic signaling in Drosophila. Dis. Model. Mech. 6, 1400-1413.
21. Gao, N., Shang, J., Huynh, D., Manthati, V. L., Arias, C., Harding, H. P., Kaufman, R. J., Mohr, I., Ron, D., Falck, J. R. et al. (2011). Mannose-6-phosphate regulates destruction of lipid-linked oligosaccharides. Mol. Biol. Cell. 22, 2994-3009.
22. Gatto, C. L. and Broadie, K. (2011). Drosophila modeling of heritable neurodevelopmental disorders. Curr. Opin. Neurobiol. 21, 834-841.
23. Gjorgjieva, J., Berni, J., Evers, J. F. and Eglen, S. J. (2013). Neural circuits for peristaltic wave propagation in crawling Drosophila larvae: analysis and modeling. Front. Comput. Neurol. 7, 24.
24. Glasheen, B. M., Kabra, A. T. and Page-McCaw, A. (2009). Distinct functions for the catalytic and hemopexin domains of a Drosophila matrix metalloproteinase. Proc. Natl. Acad. Sci. USA 106, 2659-2664.
25. Glasheen, B. M., Robbins, R. M., Piette, C., Beitel, G. J. and Page-McCaw, A. (2010). A matrix metalloproteinase mediates airway remodeling in Drosophila. Dev. Biol. 344, 772-783.
26. Godenschwege, T. A., Pohar, N., Buchner, S. and Buchner, E. (2000). Inflated wings, tissue autolysis and early death in tissue inhibitor of metalloproteinases mutants of Drosophila. Eur. J. Cell Biol. 79, 495-501.
27. Gratz, S. J., Cummings, A. M., Nguyen, J. N., Hamm, D. C., Donohue, L. K., Harrison, M. M., Wildonger, J. and O'Connor-Giles, K. M. (2013). Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 194, 1029-1035.
28. Grünewald, S. (2009). The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim. Biophys. Acta. 1792, 827-834.
29. Haeuptle, M. A. and Hennet, T. (2009). Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides. Hum. Mutat. 30, 1628-1641.
30. Himmelreich, N., Kaufmann, L. T., Steinbeisser, H., Körner, C. and Thiel, C. (2015). Lack of phosphomannomutase 2 affects Xenopus laevis morphogenesis and the non-canonical Wnt5a/Ror2 signalling. Inherit. Metab. Dis. 38, 1137-1146.
31. Jaeken, J. (2010). Congenital disorders of glycosylation. Ann. N. Y. Acad. Sci. 1214, 190-198.
32. Jaeken, J. (2013). Congenital disorders of glycosylation. Handb. Clin. Neurol. 113, 1737-1743.
33. Jaeken, J., Vanderschueren-Lodeweyckx, M., Casaer, P., Snoeck, L., Corbeel, L., Eggermont, E. and Eeckels, R. (1980). Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome? Pediatr. Res. 14, 179.
34. Jia, Q., Liu, Y., Liu, H. and Li, S. (2014). Mmp1 and Mmp2 cooperatively induce Drosophila fat body cell dissociation with distinct roles. Sci. Rep. 4, 7535.
35. Jumbo-Lucioni, P., Parkinson, W. and Broadie, K. (2014). Overelaborated synaptic architecture and reduced synaptomatrix glycosylation in a Drosophila classic galactosemia disease model. Dis. Model. Mech. 7, 1365-1378.
36. Katoh, T. and Tiemeyer, M. (2013). The N's and O's of Drosophila glycoprotein glycobiology. Glycoconj. J. 30, 57-66.
37. Katoh, T., Takase, J., Tani, Y., Amamoto, R., Aoshima, N., Tiemeyer, M., Yamamoto, K. and Ashida, H. (2013). Deficiency of α-glucosidase I alters glycoprotein glycosylation and lifespan in Caenorhabditis elegans. Glycobiology 23, 1142-1151.
38. Kerr, K. S., Fuentes-Medel, Y., Brewer, C., Barria, R., Ashley, J., Abruzzi, K. C., Sheehan, A., Tasdemir-Yilmaz, O. E., Freeman, M. R. and Budnik, V. (2014). Glial wingless/Wnt regulates glutamate receptor clustering and synaptic physiology at the Drosophila neuromuscular junction. J. Neurosci. 34, 2910-2920.
39. Kessenbrock, K., Plaks, V. and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
40. Kjaergaard, S., Kristiansson, B., Stibler, H., Freeze, H. H., Schwartz, M., Martinsson, T. and Skovby, F. (1998). Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type 1A. Acta Paediatr. 87, 884-888.
41. Kohsaka, H., Takasu, E., Morimoto, T. and Nose, A. (2014). A group of segmental premotor interneurons regulates the speed of axial locomotion in Drosophila larvae. Curr. Biol. 24, 2632-2642.
42. Koles, K., Lim, J.-M., Aoki, K., Porterfield, M., Tiemeyer, M., Wells, L. and Panin, V. (2007). Identification of N-glycosylated proteins from the central nervous system of Drosophila melanogaster. Glycobiology 17, 1388-1403.
43. Kurosaka, A., Yano, A., Itoh, N., Kuroda, Y., Nakagawa, T. and Kawasaki, T. (1991). The structure of a neural specific carbohydrate epitope of horseradish peroxidase recognized by anti-horseradish peroxidase antiserum. J. Biol. Chem. 266, 4168-4172.
44. Lin, D. M. and Goodman, C. S. (1994). Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron 13, 507-523.
45. Llano, E., Pendás, A. M., Aza-Blanc, P., Kornberg, T. B. and López-Otín, C. (2000). Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development. J. Biol. Chem. 275, 35978-35985.
46. Llano, E., Adam, G., Pendás, A. M., Quesada, V., Sánchez, L. M., Santamariá, I., Noselli, S. and López-Otín, C. (2002). Structural and enzymatic characterization of Drosophila Dm2-MMP, a membrane-bound matrix metalloproteinase with tissue-specific expression. J. Biol. Chem. 277, 23321-23329.
47. Mair, W., Piper, M. D. W. and Partridge, L. (2005). Calories do not explain extension of life span by dietary restriction in Drosophila. PLoS Biol. 3, e223.
48. Marquardt, T. and Denecke, J. (2003). Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur. J. Pediatr. 162, 359-379.
49. Martin, P. T. (2003). Glycobiology of the neuromuscular junction. J. Neurocyt. 32, 915-929.
50. Mathew, D., Ataman, B., Chen, J., Zhang, Y., Cumberledge, S. and Budnik, V. (2005). Wingless signaling at synapses is through cleavage and nuclear import of receptor DFrizzled2. Science 310, 1344-1347.
51. Matthijs, G., Schollen, E., Van Schaftingen, E., Cassiman, J.-J. and Jaeken, J. (1998). Lack of homozygotes for the most frequent disease allele in carbohydrate deficient glycoprotein syndrome type 1A. Am. J. Hum. Genet. 62, 542-550.
52. Mayatepek, E. and Kohlmüller, D. (1998). Mannose supplementation in carbohydrate-deficient glycoprotein syndrome type I and phosphomannomutase deficiency. Eur. J. Pediatr. 157, 605-606.
53. Min, K.-J. and Tatar, M. (2006). Restriction of amino acids extends lifespan in Drosophila melanogaster. Mech. Ageing Dev. 127, 643-646.
54. Monin, M.-L., Mignot, C., De Lonlay, P., Héron, B., Masurel, A., Mathieu-Dramard, M., Lenaerts, C., Thauvin, C., Gérard, M., Roze, E. et al. (2014). 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J. Rare Dis. 9, 207.
55. Müller, D., Jagla, T., Bodart, L. M., Jährling, N., Dodt, H.-U., Jagla, K. and Frasch, M. (2010). Regulation and functions of the lms homeobox gene during development of embryonic lateral transverse muscles and direct flight muscles in Drosophila. PLoS ONE 5, e14323.
56. Nichols, C. D., Becnel, J. and Pandey, U. B. (2012). Methods to assay Drosophila behavior. J. Vis. Exp. 61, e3795.
57. Packard, M., Koo, E. S., Gorczyca, M., Sharpe, J., Cumberledge, S. and Budnik, V. (2002). The Drosophila Wnt, wingless, provides an essential signal for pre- and postsynaptic differentiation. Cell 111, 319-330.
58. Page-McCaw, A., Ewald, A. J. and Werb, Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221-233.
59. Parkinson, W., Dear, M. L., Rushton, E. and Broadie, K. (2013). N-glycosylation requirements in neuromuscular synaptogenesis. Development 140, 4970-4981.
60. Pohar, N., Godenschwege, T. A. and Buchner, E. (1999). Invertebrate tissue inhibitor of metalloproteinase: structure and nested gene organization within the synapsin locus is conserved from Drosophila to human. Genomics 57, 293-296.
61. Reiter, L. T., Potocki, L., Chien, S., Gribskov, M. and Bier, E. (2001). A systematic analysis of human disease-associated gene sequences in Drosophila. Genome Res. 11, 1114-1125.
62. Ristow, M. and Schmeisser, S. (2011). Extending life span by increasing oxidative stress. Free Radic. Biol. Med. 51, 327-336.
63. Rohrbough, J., Rushton, E., Woodruff, E., III, Fergestad, T., Vigneswaran, K. and Broadie, K. (2007). Presynaptic establishment of the synaptic cleft extracellular matrix is required for post-synaptic differentiation. Genes Dev. 21, 2607-2628.
64. Rushton, E., Rohrbough, J., Deutsch, K. and Broadie, K. (2012). Structurefunction analysis of endogenous lectin mind-the-gap in synaptogenesis. Dev. Neurobiol. 72, 1161-1179.
65. Sarkar, M., Leventis, P. A., Silvescu, C. I., Reinhold, V. N., Schachter, H. and Boulianne, G. L. (2006). Null mutations in Drosophila N-acetylglucosaminyltransferase I produce defects in locomotion and a reduced life span. J. Biol. Chem. 281, 12776-12785.
66. Schneider, A., Thiel, C., Rindermann, J., De Rossi, C., Popovici, D., Hoffmann, G. F., Gröne, H.-J. and Körner, C. (2011). Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice. Nat. Med. 18, 71-73.
67. Schulte-Merker, S. and Stainier, D. Y. R. (2014). Out with the old, in with the new: reassessing morpholino knockdowns in light of genome editing technology. Development 141, 3103-3104.
68. Scott, H. and Panin, V. M. (2014a). N-glycosylation in regulation of the nervous system. Adv. Neurobiol. 9, 367-394.
69. Scott, H. and Panin, V. M. (2014b). The role of protein N-glycosylation in neural transmission. Glycobiology 24, 407-417.
70. Seppo, A. and Tiemeyer, M. (2000). Function and structure of Drosophila glycans. Glycobiology 10, 751-760.
71. Sharma, V., Ichikawa, M., He, P., Bravo, Y., Dahl, R., Ng, B. G., Cosford, N. D. P. and Freeze, H. H. (2011). Phosphomannose isomerase inhibitors improve Nglycosylation in selected phosphomannomutase-deficient fibroblasts. J. Biol. Chem. 286, 39431-39438.
72. Silvaggi, N. R., Zhang, C., Lu, Z., Dai, J., Dunaway-Mariano, D. and Allen, K. N. (2006). The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1a. J. Biol. Chem. 281, 14918-14926.
73. Sokolowski, M. B. (1980). Foraging strategies of Drosophila melanogaster: a chromosomal analysis. Behav. Genet. 10, 291-302.
74. Song, W., Henquet, M. G. L., Mentink, R. A., van Dijk, A. J., Cordewener, J. H. G., Bosch, D., America, A. H. P. and van der Krol, A. R. (2011). N-glycoproteomics in plants: perspectives and challenges. J. Proteomics 74, 1463-1474.
75. Speese, S. D., Ashley, J., Jokhi, V., Nunnari, J., Barria, R., Li, Y., Ataman, B., Koon, A., Chang, Y.-T., Li, Q. et al. (2012). Nuclear envelope budding enables large ribonucleoprotein particle export during synaptic Wnt signaling. Cell 149, 832-846.
76. Stanley, P., Schachter, H. and Taniguchi, N. (2009). N-Glycans. In Essentials of Glycobiology (ed. A. Varki, R. D. Cummings, J. D. Esko, H. H. Freeze, P. Stanley, C. R. Bertozzi, G.W. Hart and M. E. Etzler), pp. 101-114. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
77. Stefanits, H., Konstantopoulou, V., Kuess, M., Milenkovic, I. and Matula, C. (2014). Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage. J. Neurosurg. Pediatr. 14, 546-549.
78. Sternlicht, M. D. and Werb, Z. (2001). How Matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Biol. 17, 463-516.
79. ten Hagen, K. G., Zhang, L., Tian, E. and Zhang, Y. (2009). Glycobiology on the fly: developmental and mechanistic insights from Drosophila. Glycobiology 2, 102-111.
80. Thiel, C. and Körner, C. (2013). Therapies and therapeutic approaches in Congenital Disorders of Glycosylation. Glycoconj J. 30, 77-84.
81. Thiel, C., Lübke, T., Matthijs, G., von Figura, K. and Körner, C. (2006). Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality. Mol. Cell. Biol. 26, 5615-5620.
82. Van Dijk, W., Koeleman, C., Van het Hof, B., Poland, D., Jakobs, C. and Jaeken, J. (2001). Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia). FEBS Lett. 494, 232-235.
83. Varki, A. and Sharon, N. (2009). Historical background and overview. In Essentials of Glycobiology (ed. A. Varki, R. D. Cummings, J. D. Esko, H. H. Freeze, P. Stanley, C. R. Bertozzi, G.W. Hart and M. E. Etzler), pp. 1-22. Cold Spring Harbor, NY: Cold Spring Harbor Lab Press.
84. Vleugels, W., Duvet, S., Peanne, R., Mir, A.-M., Cacan, R., Michalski, J.-C., Matthijs, G. and Foulquier, F. (2011). Identification of phosphorylated oligosaccharides in cells of patients with a congenital disorders of glycosylation (CDG-I). Biochimie 93, 823-833.
85. Wang, X. and Page-McCaw, A. (2014). A matrix metalloproteinase mediates longdistance attenuation of stem cell proliferation. J. Cell Biol. 206, 923-936.
86. Yuste-Checa, P., Gámez, A., Brasil, S., Desviat, L. R., Ugarte, M., Pérez-Cerdá, C. and Pérez, B. (2015). The effects of PMM2-CDG-causing mutations on the folding, activity, and stability of the PMM2 protein. Hum. Mutat. 36, 851-860.
87. Zaffran, S., Astier, M., Gratecos, D. and Sémériva, M. (1997). The held out wings (how) Drosophila gene encodes a putative RNA-binding protein involved in the control of muscular and cardiac activity. Development 124, 2087-2098.
88. Zhang, L. and Ward, R. E. (2009). uninflatable encodes a novel ectodermal apical surface protein required for tracheal inflation in Drosophila. Dev. Biol. 336, 201-212.